Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis

01.02.1989

Englisch

9780306430374

Springer US

Nein

362

1988

Gebundene Ausgabe

atherosclerosis, high-density lipoprotein (HDL), protein complexes, protein, genetics, heart, cytokine, Lipoprotein, tertiary structure

PSB - Biochemie MJD - Kardiologie, Angiologie

Eicosanoids.- Prostacyclin, EDRF and Atherosclerosis.- Control of Prostacyclin Production by Vascular Cells: Role of Adenine Nucleotides and Serotonin.- Prostacyclin and Atherosclerosis — Experimental and Clinical Approaches.- Platelet-Neutrophil Interactions in the Eicosanoid Pathway.- Arterial Cell Interactions: Mechanistic Studies Related to Eicosanoid and Growth Factor-Induced Alterations in Cholesterol Metabolism.- Effects of Plasma Lipoproteins on Eicosanoid Metabolism by Cultured Vascular Smooth Muscle Cells.- Eicosanoid Synthesis in Platelet-Derived Growth Factor-Stimulated Fibroblasts.- Genetics of Apolipoproteins.- Genetic HDL Deficiency States.- Apolipoprotein A-I: Deficiency in Tangier Disease.- Apolipoprotein C-II Deficiencies: In Vivo Models for Assessing the Significance of Defective Lipolysis on Lipoprotein Metabolism 7.- Genetic Variation in the Apolipoproteins C-II and C – III.- The Effect of Apolipoprotein E Allele Substitutions on Plasma Lipid and Apolipoprotein Levels.- Molecular Genetics of Coronary Heart Disease.- STRUCTURE OF APOLIPOPROTEINS AND LIPOPROTEINS.- Molecular Biology of Human Apolipoprotein B and Related Diseases.- Secondary and Tertiary Structure of Apolipoproteins.- Prediction of the Tertiary Structure of Apolipoprotein A-II by Computer Modeling.- Relationship between Structure and Metabolism of HDL Apolipoproteins: Study with Synthetic Peptides.- Heterogeneity in the Conformation of Apo A-I on the Surface of HDL Particles.- Structural Properties of the Heparin-Binding Domains of Human Apolipoprotein E.- Characterization and Metabolism of Glycated High Density Lipoproteins in Diabetic Patients.- Control of Spontaneous Lipid and Protein Transport.- Modifications in the Chemical Composition and Thermometric Behavior of LDL and HDL by Probucol in Type Ila Hyperlipoproteinemia.- Acute Phase Apolipoproteins.- Serum Amyloid A (SAA) — The Precursor of Protein AA in Secondary Amyloidosis.- Modulation of Serum Amyloid A Gene Expression by Cytokines and Bacterial Cell Wall Components.- Protein S and SAA : Genetics, Structure and Metabolism. Are They Apolipoproteins and Identical?.- LIPID TRANSFER PROTEINS.- Plasma Cholesteryl Ester and Phospholipid Transfer Proteins and Their Regulation.- The Human Plasma Cholesteryl Ester Transfer Protein: Structure, Function and Physiology.- Cholesterol Ester Transfer Protein. Characterization of Monoclonal Antibodies against the Human Antigen.- Cholesterol Esterification and Net Mass Transfer of Cholesterylesters and Triglycerides in Plasma from \ Healthy Subjects and Hyperlipidemic Coronary Heart Disease Patients.- Lecithin: Cholesterol Acyltransferase and Its Action on Different Substrates.- In Vivo Evidence for Cholesterol Ester and Triglyceride Exchange between High Density Lipoprotein and Infused Triglyceride Rich Particles in Abetalipoproteinemia 2.- Enhanced Cholesteryl Ester Transfer Activity in Cyclophosphamide-Treated Rabbits: Relationship with Lipolytic Enzymes.- Role of Apolipoprotein A IV in the Interconversion of HDL Subclasses.- LIPOPROTEIN PARTICLES.- HDL Receptor and Reverse Cholesterol Transport in Adipose Cells.- Molecular Analysis of Atherogenic Lipoprotein Particles in Adequately Controlled Type I Diabetes Mellitus.- Quantitative Abnormalities of Lipoprotein Particles in Chronic Hemodialysis Patients....283.- HYPERTRIGLYCERIDEMIA.- Lipoprotein Particles in Hypertriglyceridemic States.- In Vivo Metabolism of Apolipoproteins C-II and C-III in Normal and Hypertriglyceridemic Sub jects.- Pathogenesis of Hypertriglyceridemia: Implications for Coronary Heart Disease and Therapy.- Increased VLDL.- Exchange and Transfer of Apolipoproteins and Lipids: Impact on Lipoprotein Metabolism.- Hypertriglyceridemia and Omega-3 Fatty Acids.- Contributors.

0 mm